E-selectin antagonist

E-selectin antagonist
Trade Name
Orphan Indication Acute myeloid leukemia
USA Market Approval USA
USA Designation Date 2015-05-13 00:00:00
Sponsor GlycoMimetics, Inc.;401 Professional Drive, Suite 250;Gaithersburg, Maryland, 20879
Related Access Program
Children’s Hospital Los Angeles – Acute myeloid leukemia Jazz Pharmaceuticals – Secondary AML Celator Pharmaceuticals – Secondary AML University of California, San Francisco – Acute myeloid leukemia Emory University – Acute myeloid leukemia